These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6249559)

  • 21. Ocular effects of topical administration of delta 9-tetrahydrocannabinol in man.
    Green K; Roth M
    Arch Ophthalmol; 1982 Feb; 100(2):265-7. PubMed ID: 6279061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The intraocular pressure response of conscious rabbits to clonidine.
    Allen RC; Langham ME
    Invest Ophthalmol; 1976 Oct; 15(10):815-23. PubMed ID: 10261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the central hypotensive effect of clonidine by trazodone, a novel antidepressant.
    van Zwieten PA
    Pharmacology; 1977; 15(4):331-6. PubMed ID: 896949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delta(9)-tetrahydrocannabinol,, euphoria and intraocular pressure in man.
    Purnell WD; Gregg JM
    Ann Ophthalmol; 1975 Jul; 7(7):921-3. PubMed ID: 1147519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance to the effects of delta 1-tetrahydrocannabinol on the pressor responses to noradrenaline in rats.
    Li DM
    Clin Exp Pharmacol Physiol; 1981; 8(2):101-8. PubMed ID: 6265124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An increase in intraocular pressure due to clonidine.
    Innemee HC; van Zwieten PA
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1978 Aug; 207(3):149-56. PubMed ID: 309734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
    Lichtman AH; Fisher J; Martin BR
    Pharmacol Biochem Behav; 2001; 69(1-2):181-8. PubMed ID: 11420084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Forskolin suppresses sympathetic neuron function and causes ocular hypotension.
    Potter DE; Burke JA; Temple JR
    Curr Eye Res; 1985 Feb; 4(2):87-96. PubMed ID: 4039243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraocular pressure following systemic administration of cannabinoids.
    Green K; Symonds CM; Oliver NW; Elijah RD
    Curr Eye Res; 1982-1983; 2(4):247-53. PubMed ID: 6295702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The influence of a combination of clonidine and acetylandromedol on blood pressure and central sympathetic tone of the cat (author's transl)].
    Tauberger G; Trunzler G; Volkert W; Flory PJ
    Arzneimittelforschung; 1978; 28(4):654-6. PubMed ID: 581943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of sympathetic cervical ganglion in the effect of clonidine for lowering intraocular pressure].
    Iizuka T; Koike N; Moriwaki Y; Ueda T; Koide R; Inatomi M; Fukado Y; Uchida E; Kobayashi S; Oguchi K
    Nippon Ganka Gakkai Zasshi; 1992 Feb; 96(2):146-51. PubMed ID: 1558011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit.
    ElSohly MA; Harland EC; Benigni DA; Waller CW
    Curr Eye Res; 1984 Jun; 3(6):841-50. PubMed ID: 6329602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol.
    Fitton AG; Pertwee RG
    Br J Pharmacol; 1982 Feb; 75(2):409-14. PubMed ID: 6313110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The central nervous influence of drugs on intraocular pressure.
    Innemee HC; van Zwieten PA
    Rev Pure Appl Pharmacol Sci; 1980; 1(2):107-65. PubMed ID: 6267661
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ocular hypotensive effect of alpha-adrenoceptor agonist and antagonist in the conscious pigmented rabbit].
    Moriwaki Y; Iizuka T; Nakamura A; Nakata K; Masaoka Y; Ueda T; Koide R; Inatomi M; Fukado Y; Uchida E
    Nippon Ganka Gakkai Zasshi; 1992 Feb; 96(2):152-60. PubMed ID: 1348394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Centrally induced hypotension by 2-(2,6-dichlorophenyl)-5,6-dihydroimidazo (2,1-b)-thiazole fumarate (compound 44-549).
    van Zwieten PA
    Pharmacology; 1975; 13(4):352-5. PubMed ID: 1187759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular hypotensive effects of an intratracheally delivered liposomal delta9-tetrahydrocannabinol preparation in rats.
    Szczesniak AM; Kelly ME; Whynot S; Shek PN; Hung O
    J Ocul Pharmacol Ther; 2006 Jun; 22(3):160-7. PubMed ID: 16808676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The simultaneous infusion of drugs via the left and right vertebral artery of the cat; a modified animal model for the study of possible central actions of drugs upon the lower brain stem.
    Porsius AJ
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):260-71. PubMed ID: 7224708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
    Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.
    Tomida I; Azuara-Blanco A; House H; Flint M; Pertwee RG; Robson PJ
    J Glaucoma; 2006 Oct; 15(5):349-53. PubMed ID: 16988594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.